Skip to content

Effectiveness of group arts therapy for mixed diagnosis community mental health patients

Effectiveness of group arts therapy compared to group counselling for diagnostically heterogeneous psychiatric community patients: RAndomised controlled trial in mental health services

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN88805048
Enrollment
420
Registered
2018-09-12
Start date
2019-02-01
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychological distress in people with schizophrenia and related psychotic disorders, mood disorders and anxiety or other non-psychotic disorders Mental and Behavioural Disorders Outpatients in secondary mental health care with primary diagnosis ICD-10 F2 (schizophrenia and related psychotic disorders), F3 (mood disorders) or F4 (anxiety and other non-psychotic disorders) with at least moderate symptom distress.

Interventions

Participants will be randomly allocated with equal chance to receive either their preferred form of group arts therapy (art, dance movement or music therapy), or group counselling. Participants will c

Sponsors

East London NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 110 Years

Inclusion criteria

Inclusion criteria: 1. Outpatient in secondary mental health care 2. Motivation to attend group arts therapy for 5 months and expression of preference for one of three forms 3. Aged 18 years or older 4. Primary diagnosis of ICD-10 - diagnosed with at least one of the following (participants are not required to be diagnosed with all three): 4.1. F2 (schizophrenia and related psychotic disorders) 4.2. F3 (mood disorders) 4.3. F4 (anxiety and other non-psychotic disorders) 5. Duration of current mental disorder of 6 months or longer 6. At least moderate symptom level on BSI (score of 1.65 or above on Global Severity Index) 7. Capacity to provide informed consent

Exclusion criteria

Exclusion criteria: 1. Primary diagnosis of organic mental disorder (F0), substance misuse (F1), personality disorder (F6) 2. Duration of current mental disorder <6 months (i.e. patients with short-term crises) 3. Physical condition that prevents attendance of group arts therapies 4. Insufficient command of English for communication with other group members and therapists.

Design outcomes

Primary

MeasureTime frame
Psychological distress, assessed using the Brief Symptom Inventory Global Severity Index, at the end of 20 weeks of treatment

Secondary

MeasureTime frame
The following are assessed at the end of 20 weeks of treatment, and 6 and 12 months post-treatment: 1. Psychological distress, assessed using the Brief Symptom Inventory (all subscales) 2. Observer-rated psychiatric symptoms, assessed using the Brief Psychiatric Rating Scale (BPRS) 3. Quality of life, assessed using the Manchester Short Assessment of Quality of Life (MANSA) 4. Objective social situation, assessed using the Objective Social Outcomes Index (SIX) 5. Use of health and social care, assessed using the Client Services Receipt Inventory (CSRI) 6. Self-related health to estimate Quality-adjusted life years (QALYS), assessed using the EQ-5D-3L questionnaire

Countries

England, United Kingdom

Contacts

Public ContactCatherine Carr
c.e.carr@qmul.ac.uk+44 (0)2075404380

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 27, 2026